Following attachment of herpes simplex virus (HSV) to cells mediated by the interaction of two virion glycoproteins, gC and gB, with cell surface glycosaminoglycans (9; for a review, see reference 46) , entry of the capsid into the cytoplasm occurs via a pH-independent fusion of the virion envelope with plasma membranes and involves at least four glycoproteins, gB, gD, and the heterodimer gH/gL (6, 15, 27, 41) . The involvement of cellular receptor proteins binding gD rests on numerous lines of evidence. First, stable expression of gD in cell lines prevents infection (1, 7, 21) . Incubation of gD-expressing cells with antibodies to gD releases the block (4, 8) . Viral unrestricted mutants able to overcome the gD-mediated block carry mutations in gD (4, 8, 11) . This suggested that expression of gD blocked infection by sequestering a cellular receptor required for HSV entry (21) . Studies on unrestricted mutants carrying different mutations in gD led to the further suggestion that multiple forms of gD-binding cellular receptors may exist (4, 40) . The notion that different gD-expressing alphaherpesviruses-HSV, pseudorabies (PRV), and bovine herpesvirus 1 (BHV-1)-may use common receptors for entry in some cell types rested on the observation that cells expressing gD of one of the viruses could restrict infection by the homologous as well as the heterologous viruses (10, 23, 38) . Finally, anti-idiotypic antibodies mimicking gD bind to cell surfaces of commonly used cell lines and block virus infectivity (19) , and cells susceptible to HSV infection bind gD in a saturable manner (20) . Similar evidence implicating cellular cognate proteins does not exist for gB, gH, or gL. Studies with the resistant CHO cells led to the identification of herpesvirus entry mediator (HVEM, now HveA) (33) , a novel member of the tumor necrosis factornerve growth factor (TNF/NGF) receptor family present primarily in activated T lymphocytes, which mediates efficient entry of some HSV-1 strains into resistant transfected cell lines.
We report the identification of a novel member of the immunoglobulin (Ig) superfamily that confers susceptibility to HSV infection by mediating entry of the virus into cells. Its identification was permitted by use of a cellular clone (J1.1-2 cells) highly resistant to HSV entry, derived by exposure of BHKtkϪ cells to a recombinant HSV expressing tumor necrosis factor alpha (TNF-␣). From a human cDNA expression library, we selected a clone encoding a protein whose ectodomain is almost identical to that of poliovirus receptor related-1 protein (PRR-1) (28) and appears to be a splice variant isoform of it. The herpesvirus Ig-like receptor (HIgR) and PRR-1 each confers susceptibility to HSV-1, HSV-2, and BHV-1. Key properties of HIgR and PRR-1 that allow them to be considered bona fide receptors for HSV-1 and HSV-2 entry are their ability to bind glycoprotein D, their wide distribution among commonly used human cell lines susceptible to HSV infection, neutralization of virion infectivity by monoclonal antibody to the ectodomain of the HIgR/PRR-1 isoforms, and expression of the mRNA in human tissues, with the highest level of expression being detected in nervous system tissues.
TGTCT CCTCC-3Ј). The PCR conditions for amplification of HIgR, PRR-1,  and HIgR plus PRR-1 sequences were 10 cycles of 95°C for 30 s, 55°C for 30 s,  and 72°C for 1 min, and then 35 cycles of 95°C for 30 s, 60°C for 30 s, and 72°C  for 1 min. The PCR conditions for amplification of HveA sequences were 35  cycles of 94°C for 1 min, 56°C for 1 min, and 72°C for 1 min (with a 3-s increase  at each new cycle) . PCR conditions for amplification of ␤-actin sequences were 45 cycles of 94°C for 1 min, 55°C for 1 min, and 72°C for 1 min. As a routine, samples were initially denatured for 4 min at 94°C.
Immunofluorescence and FACS analysis. For immunofluorescence, cells grown in glass coverslips were fixed with acetone and reacted with MAb R1.302 (1:100) followed by biotinylated anti-mouse antibodies (Vectastain ABC kit) and Extravidin-tetramethylrhodamine-5-isothiocyanate (TRITC) (Sigma). Fluorescence-activated cell sorter (FACS) analysis was performed as described previously (29) and analyzed in a FACSscan flow cytometer.
Infectivity neutralization assays. Cells grown in 96-well trays were preincubated with the indicated amounts of antibodies, either purified IgGs or ascites fluid, in 25 l of medium for 2 h at 4°C. The appropriate amount of R8102 in 7.5 l was then added for a further 90 min at 4°C. The viral inoculum was removed, and the cells were rinsed twice, overlaid with medium containing the same concentration of antibodies as present during the preabsorption, shifted to 37°C, and incubated for 16 h. ␤-Galactosidase activity was assayed as described previously (33) . The optical density was read in a Bio-Rad enzyme-linked immunosorbent assay reader. For each antibody concentration, triplicate experiments were run. Data represent the average of at least two experiments. The 100% value represents data obtained with infected cells not exposed to antibodies. Infectivity neutralization was detected irrespective of whether purified IgGs or ascites fluids were used.
Northern blot analysis. Human multiple-tissue Northern (MTN) membranes (Clontech) were hybridized with the BamHI fragment from pLX1.12 labeled with [
32 P]dCTP, as specified by the manufacturer. The membranes were also probed with a ␤-actin probe to verify the hybridation conditions.
Binding of gD to J1.1-2 cells expressing HIgR. J1.1-2 cells in glass coverslips were transfected with pCF18, fixed with methanol 30 h later, incubated with biotinylated recombinant gD-1(⌬290-299t) (0.1 g in 30 l/coverslip) (36) for 1 h at room temperature followed by Extravidin-TRITC (Sigma) (1:100 in phosphate-buffered saline containing 20% fetal calf serum) for 1 h at room temperature. For biotinylation, 7 g of gD was incubated with 1 g of Immunopure sulfo-NHS-biotin (Pierce) in 50 mM sodium bicarbonate buffer (pH 8.5) for 2 h on ice.
RESULTS
Derivation of the J1.1-2 cell line, which is highly resistant to HSV infection. Of the numerous attempts to obtain a cell line resistant to infection by exposing different cell lines to a variety of HSV strains, the one that yielded the most useful cell line involved exposure of BHKtkϪ cells to recombinant HSV R8996, which secretes TNF-␣ in the medium. The few cells surviving a 10-PFU/cell infection were grown and infected two more times with the same virus at 100 PFU/cell. Some cells in the culture showed a persistent cytopathic effect, which was eliminated by cultivation of the cells for 20 days in the presence of HD-1 ascites fluid (1:250), a potent neutralizing monoclonal antibody to gD (37) , and for an additional 20 days in the presence of a mixture of HD-1 and 52S (45), a neutralizing antibody to gH. The cells were cloned by single-cell plating with medium supplemented with 20% fetal calf serum and 20% conditioned medium from BHKtkϪ cells. Twelve clones were assayed for resistance to infection with R8102, which carries a lacZ gene fused to ␣-27, and infection was monitored by X-Gal staining. All clones were resistant to infection. In clone J1.1-2, no more than an average of 10 cells per monolayer (3 ϫ 10 6 cells) exhibited evidence of infection after exposure to 5 PFU/cell (Fig. 1A) . The J1.1-2 cells have been propagated for about 1 year without exhibiting a change in phenotype.
Resistance in clone J1.1-2 is at the entry level. In HSVinfected cells, ␣ gene expression does not require prior viral protein synthesis. In R8102, the lacZ gene was driven by the ␣27 promoter. Thus, lack of lacZ expression indicated that the block to infection with R8102 in J1.1-2 cells preceded ␣ gene expression. Additional evidence that block is at the entry level was as follows. (i) At 4°C, HSV attaches to but does not penetrate cells. We compared the extent of virus attachment to J1.1-2 and BHKtkϪ cells by measuring the amount of virus remaining unattached after 120 min of absorption at 4°C and found no difference (Fig. 1B). (ii) In the second experiment, J1.1-2 cells were transfected with the mediator of HSV entry, HVEM(HveA), and infected with R8102. The cells became infectable (Fig. 1C) .
Selection of a human cDNA clone that confers susceptibility to J1.1-2. J1.1-2 cells were transfected with DNA pools from a HeLa cDNA library, exposed to R8102 30 h after transfection, and monitored for ␤-galactosidase activity. The protocol described in Materials and Methods led to the selection of clone pCF18, which conferred susceptibility to all the transfected cells in the culture (Fig. 1D) .
The approximately 2,500-bp insert in pCF18 contained an open reading frame predicted to encode a 458-amino-acid protein (designated HIgR) of 50.7 kDa (Fig. 2 ). The predicted protein had structural elements typical of type 1 membranebound proteins, an N-terminal signal sequence with cleavage at Ser30, and a hydrophobic transmembrane region at residues 346 to 369. The ectodomain carried, in addition to seven potential N-glycosylation sites, six cysteine residues and consensus Ig motifs which identified three domains, one V-like and two C-like, of 72, 53, and 46 residues, respectively ( Fig. 2 ) (a representation of the predicted structure is shown in Fig. 3A ). These features defined the protein encoded by pCF18 as belonging to the Ig superfamily. The sequence was identical up to nucleotide 1002 to that of PRR-1 cDNA (28), except for the absence of three nonconsecutive cytosines, which modified the amino acid sequence between residues 194 and 204 (Fig. 2) . Divergence between HIgR and PRR-1 started at nucleotide 1002 immediately after a splice donor consensus sequence. Since alternative splicing is very frequent among Ig superfamily transcripts, e.g., in poliovirus receptor (PVR) (25) and PRR-2 (13), it seems highly probable that the cDNA encoded by pCF18 represents a previously unknown, alternative splice variant of PRR-1. HIgR has a shorter C-terminal cytoplasmic tail than PRR-1 ( Fig. 2 and 3A ). This is similar to PRR-2␣ and PRR-2␦, which share the ectodomain and differ in the size and sequence of the cytoplasmic tail (13) .
In vitro transcription-translation of pCF18 yielded a protein with an apparent mass of 57 kDa (Fig. 3B) . The apparent molecular mass increased to 70 kDa in the presence of microsomes and showed discrete intermediate bands, consistent with glycosylation of some of the predicted sites.
HIgR confers susceptibility to a wide range of HSV-1 and HSV-2 strains. Preliminary experiments established that J1.1-2 cells were simultaneously resistant to all HSV-1 and HSV-2 strains tested. These included the wild-type strains HSV-1(F), HSV-1(KOS), HSV-1(SC-16), and HSV-2(G); the two syncytial strains HSV-1(MP) and HSV-1(HFEM) with mutations in gK (39) and gB (12, 42) , which induce polykaryocyte formation of infected cells; four strains with mutations in gD which overcome gD-mediated block to infection, three of which (U21, U30, and U10) were selected in our laboratory (4, 8) ; and ANG, a clinical isolate (11, 43) . Lack of plaque formation (Fig.  4 shows representative examples) or immunostaining of monolayers ( Fig. 5a shows an example) were used to assess resistance to infection.
To determine the range of HSV strains to which HIgR Fig. 5f and h ). The characteristic of J1.1-2 cells of resistance to a wide range of HSV strains differentiates J1.1-2 from CHO cells, which show moderate resistance to HSV-2 and to the syncytial strain MP. Furthermore, transfection of CHO cells with HveA increased their susceptibility to HSV-2 and to syncytial strain MP to a low level and did not induce susceptibility to the HSV gD mutants able to overcome the gD-mediated block (33) . In contrast to HveA, transfection of J1.1-2 cells with HIgR conferred high sensitivity to all HSV-1 and HSV-2 strains tested. We also noticed that HIgR was much more efficient than HveA(HVEM) in conferring on J1.1-2 cells susceptibility to infection with HSV-2 and the syncytial strains MP, HFEM, and ANG (compare Fig. 5d to e, Fig. 5f to g, and Fig. 5h to i) .
PRR-1 confers susceptibility on J1.1-2 cells. J1.1-2 cells were transfected with pLX1.12 containing pPRR-1 cDNA and 30 h later were exposed to R8102. PRR-1 was as effective as HIgR Transfection with HIgR or PRR-1 confers susceptibility to BHV-1. As mentioned in the introduction, studies on restriction mediated by gD homologs encoded by HSV, BHV-1, and PRV suggest the possibility that the three alphaherpesviruses use common receptors in some cell lines (10, 23, 38) . As shown in Fig. 7a , J1.1-2 cells were not susceptible to BHV-1 infection. However, susceptibility was restored by transfection with HIgR or PRR-1 ( Fig. 7b and c) . Somewhat to our surprise, J1.1-2 cells were susceptible to PRV infection; therefore, the effect of HIgR or PRR-1 expression on this virus could not be investigated. With respect to BHV-1, the results indicate that although HIgR and PRR-1 do not represent the natural receptors used by BHV-1 in bovine cells and in its natural host, the human HIgR or PRR-1 can be used promiscuously by BHV-1 to enter the cells. With respect to PRV, the results indicate that in J1.1-2 cells this virus finds a receptor, which cannot be utilized by HSV-1, HSV-2, or BHV-1.
HIgR or PRR-1 mRNAs are present in human cell lines. A central question is whether the gene encoding HIgR or PRR-1 is expressed in cells susceptible to HSV-1 infection. A prelim-
inary assay for the presence of HIgR or PRR-1 mRNAs was performed by RT-PCR of RNA extracted from a number of cell lines susceptible to HVS infection and from J1.1-2 cells. Three sets of primers were used. The first set amplified the 5Ј portion of the mRNAs in common between the two isoforms and therefore cumulatively amplified sequences of HIgR and PRR-1 (HIgRϩPRR-1) (Fig. 8A) . The other two sets of primers annealed to the 3Ј portions of the mRNAs and were therefore specific either for HIgR or for PRR-1 ( Fig. 8B and C) . All cells of human origin, susceptible to HSV infection, i.e., HeLa, HEp-2, MRC human fibroblasts, TF-1, and U937, contained mRNAs for HIgR or PRR-1, or both, indicating that mRNAs for these molecules are widely expressed in human cells. Vero cells of simian origin also contained sequences amplified with the primers designed on the basis of the human gene sequence, suggesting the possible existence of a simian homolog. BHKtkϪ cells, which are susceptible to HSV infection but of hamster origin, did not. This probably reflects the specificity of the primers for the human gene and stringency of PCR conditions. The results with human cell lines are consistent with and extend previous data (16) .
The same cells were tested for presence of HveA mRNA by RT-PCR with specific primers. Only some cells were positive (Fig. 8D) , confirming that HveA expression is limited to a few cell types (33) . As a control, ␤-actin mRNA could be amplified from all cell lines tested (Fig. 8E) . With respect to the mechanism of action of HIgR, the inference from this experiment is that HIgR enables HSV to enter J1.1-2 cells without the need for cooperation by HveA.
Distribution of HIgR or PRR-1 proteins in human cell lines.
To ascertain if HIgR and PRR-1 are the authentic receptors used by HSV in human cell lines, it was crucial to detect the expression of these molecules at the protein level. We used a MAb to PRR-1 previously derived in one of our laboratories, designated MAb R1.302 (29) . Since MAb R1.302 reacted with cells expressing HIgR (results not shown), the epitope recognized by MAb R1.302 must reside in the ectodomain of the two molecules. The distribution of HIgR and/or PRR-1 proteins was next investigated by flow cytometry or by indirect immunofluorescence and found to be positive on numerous human cell lines, i.e., HEp-2 and HeLa (epithelial cell carcinoma), TF-1 (hematopoietic progenitor), IMR-32 and Lan5 (neuroblastoma), Nalm-6 (lymphoid, precursor B), and 5637 and T24 (epithelial bladder carcinoma) (representative examples shown in Fig. 9 ). Previously, reactivity to MAb R1.302 was 
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on November 7, 2017 by guest http://jvi.asm.org/ ing concentrations of MAb R1.302 before infection inhibited R8102 infectivity in a dose-dependent manner (Fig. 10A) .
Mouse IgGs had only a minor inhibitory effect. To ascertain if the HIgR or PRR-1 molecules detected in human cell lines are actually used as receptors by HSV, we carried out infectivity neutralization experiments on representative cell lines. The results in Fig. 10B and C show that in HEp-2, HeLa, TF-1, and 5637 cells, HSV infectivity was reduced in a dose-dependent fashion by MAb R1.302 whereas an unrelated MAb had only minimal effects. From these data, we can draw three conclusions. First, the experiment provides compelling evidence that susceptibility to infection in HIgR-and PRR-1-expressing J1.1-2 cells is dependent upon a direct interaction of virions with these molecules. Second, infectivity neutralization in human cell lines, coupled with protein expression, demonstrates that these molecules are actually used as receptors for entry. Third, since the portion of the molecule shared by HIgR and PRR-1 is the ectodomain (Fig. 2) , the functional domain of HIgR or PRR-1 used to mediate HSV entry maps to the ectodomain of the molecules.
Distribution of HIgR or PRR-1 mRNAs in human tissues.
In this experiment, the expression of HIgR and/or PRR-1 in human tissues was assessed by Northern blot analysis carried out on human multiple-tissue Northern blot membranes from Clontech. The probe consisted of the BamHI fragment of pLX1.12 comprising the entire PRR-1 cDNA, and it hybridized to both HIgR and PRR-1 mRNAs. The results in Fig. 11 show that two bands of 5.9 and 3.5 kbp were detectable in several tissues. The highest level of expression was detected in samples from the nervous tissue, brain, and spinal cord, followed by the trachea, prostate, and pancreas.
Cells expressing HIgR bind gD. J1.1-2 cells transfected with pCF18 or pcDNA3.1 were reacted with a biotinylated recombinant soluble form of gD [gD-1(⌬290-299t)] (36) followed by TRITC-conjugated Extravidin. The results in Fig. 12b alone (Fig. 12a) or pCF18-transfected cells treated with Extravidin in the absence of gD (results not shown) were not labeled. Overlapping results were obtained with pLX1.12-transfected J1.1-2 cells (results not shown).
DISCUSSION
The key discovery reported here is that a novel member of the Ig superfamily, HIgR, which shares the ectodomain with PRR-1, and PRR-1 itself act as bona fide receptors for HSV-1 and HSV-2 entry into human cells.
The discovery of HIgR was made possible by use of the J1.1-2 cell line, which is highly resistant to entry of HSV-1, HSV-2, and BHV-1; this cell line was selected by repeated exposures of BHKtkϪ cells to a recombinant HSV strain expressing TNF-␣. Screening of a human cDNA expression library for clones that restored susceptibility to J1.1-2 cells led to the isolation of a human cDNA clone which encodes a novel transmembrane protein with features typical of the Ig superfamily and an overall molecular organization essentially overlapping that of PVR (31), i.e., a V-like and two C-like domains bracketed by conserved cysteines. Its predicted amino acid sequence is almost identical, until amino acid 335, to that of PRR-1 (28) . HIgR and PRR-1 diverge after a consensus sequence for a splice donor. Alternative splicing is a very generalized phenomenon in the Ig superfamily and contributes to the generation of Ig diversity. For example, PVR mRNAs originate from a 20-kb transcript, consist of eight exons, and, because of alternative splicing, yield at least four different transmembrane and secreted forms of the receptor (25) . Similarly, the hPRR-2 homolog of PRR-1 exists in two forms, ␣ and ␦ (13), which have an identical 5Ј sequence and diverge in the 3Ј portion (1,041 of 1,413 bp identical). On this basis, it seems likely that HIgR originates by alternative splicing of PRR-1 transcript.
While the manuscript was being readied for publication, it was reported that PRR-1, renamed HveC (for herpesvirus entry mediator C), mediates the entry of HSV-1, HSV-2, BHV-1, and PRV; that PVR itself can mediate the entry of PRV (16); and that PRR-2, renamed HveB (for herpesvirus entry mediator B), mediates the entry of HSV-1 gD-mutants and HSV-2 but not wild-type HSV-1 strains (48) .
The relevant properties of HIgR and PRR-1(HveC) as mediators of HSV entry into human cells are as follows. (i) HIgR and PRR-1 permit the entry of all wild-type and mutant HSV-1 and HSV-2 strains tested, including mutants which induce the fusion of cells and mutants which overcome the gD-mediated restriction to infection. This property differentiates HIgR and PRR-1 (16) from HveA, which shows a narrower viral spectrum (33) .
(ii) HIgR and PRR-1 permit HSV entry into J1.1-2 cells independently of each other and of HveA.
(iii) Cells expressing HIgR or PRR-1 bind gD, as expected from numerous studies pointing to gD as the virion component engaged in virus entry through interaction with cellular receptor molecules.
(iv) The HIgR and/or PRR-1 isoforms are highly distributed among human cell lines susceptible to HSV infection and commonly used for HSV studies, such as HEp-2, HeLa, human fibroblasts, U937, and numerous other human cell lines of different origin, such as IMR-32 and Lan5 (neuroblastoma), TF-1 (hematopoietic progenitor), 5637 and T24 (bladder carcinoma), Nalm-6 (lymphoid, precursor B), and plasmacytoid cells and T lymphocytes (29) . mRNA analysis showed that some of these cell lines express one or the other isoform while some express both.
(v) A MAb to PRR-1 neutralizes HSV-1 infectivity in HIgRor PRR-1-transformed cells as well as in human cell lines. This provides unambiguous evidence of the actual usage of these molecules as HSV-1 receptors in human cell lines. It also shows that viral entry mediated by HIgR or PRR-1 occurs through a direct interaction of the receptor molecules with virions.
(vi) HIgR and PRR-1 are two isoforms sharing the ectodomain. Thus, the functional domain that mediates alphaherpesvirus entry must reside in the ectodomain of the molecules.
(vii) HIgR and PRR-1 mRNAs are expressed in human tissues; the highest level of expression is detected in samples from the nervous system.
HIgR adds a novel member to the cluster of Ig homologs, which includes PVR, hPRR-1, hPRR-2␣ and ␦, and homologous proteins of simian, murine, and rat origin (3, 13, 25, 26, 28, 31, 34) . They share three characteristics: (i) a common molecular structure defined by the six conserved cysteins (Fig.  3A) , (ii) the ability to originate multiple isoforms by alternative 
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on November 7, 2017 by guest http://jvi.asm.org/ splicing, and (iii) the ability of the human members to mediate the entry of some alphaherpesviruses. The discovery of a novel member of the cluster suggests the possibility that the actual number of members capable of acting as receptors for herpesviruses is even larger than that known to date. It will be interesting to determine whether animal isoforms of the cluster can mediate HSV entry into animal cells, providing a basis for the broad host range of HSV in cell cultures and animals of different species.
In the past, proteins proposed as mediators of HSV entry were subsequently brought into question because of failure to comply with authenticity criteria. For basic fibroblast receptor (22) , transfection in resistant cells did not enhance virus entry (32, 35, 44) . For mannose-6-phosphate receptors, cell mutants defective in the expression of these proteins were infectable by HSV (5). Here we show that HIgR and PRR-1 fulfill criteria that allow them to be considered bona fide receptors for HSV-1 and HSV-2. First, these proteins are present in a variety of human cells susceptible to HSV infection, as detected by reactivity with MAbs. Second, the neutralizing activity of the antibody in the same cells which express the HIgR or PRR-1 proteins provides unambiguous evidence for the actual usage of these receptors in human cell lines. Third, since the virus must infect neurons to establish latency, the finding that mRNAs for HIgR or PRR-1 are expressed in human tissues, with the highest expression being detected in nervous-system samples, makes infection in humans feasible.
The present work confirms and extends the report on PRR-1(HveC) (16) 
